Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Kongo vs yourEra

Kongo
Graded #27

Level

vs
yourEra
Graded #13

Level

The verdict

Too close to call — both grade 83.8/100 (B).

Kongo and yourEra land on the same WeighScore, so neither clears the other on our six graded dimensions. yourEra sits one line higher on the board (#13 vs #27) on the underlying tiebreak, but it's a genuine coin-flip — pick on the factors and prices that matter most to you below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueKongo +4
86
82
Dose & formulationyourEra +2
80
82
Clinical oversightyourEra +1
84
85
Labs & monitoringyourEra +3
82
85
FulfillmentKongo +1
87
86
Contract termsEven
85
85
Kongo · left baryourEra · right bar

The numbers

MetricKongoyourEra
WeighScore83.8/10083.8/100
GradeBB
Scorecard rank#27#13
Semaglutide$119/mo$199/mo
Tirzepatide$229/mo$299/mo
CoverageAll 50 statesAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Kongo

Graded #27 · B

Strengths

  • $119 semaglutide
  • All 50 states, LegitScript-verified
  • Both molecules

Where it loses points

  • Tirzepatide jumps to $229/mo
  • Injection-only
  • Monitoring detail sparse
yourEra

Graded #13 · B

Strengths

  • Transparent, publicly listed pricing — many compounded competitors hide price behind a quiz
  • Both semaglutide and tirzepatide, not a single-drug menu, plus NAD+ and microdosing lines
  • Markets a 50-state licensed-clinician network; no insurance required, HSA/FSA accepted
  • Optional yourEra Optimum membership adds 1:1 coaching, a nutritionist, at-home lab draws and wearables

Where it loses points

  • Compounded semaglutide/tirzepatide are not FDA-approved (not the same as Wegovy/Ozempic/Zepbound)
  • Mid-market pricing ($199 sema / $299 tirz) — above the cheapest compounders
  • No brand-name lane and no oral route — weekly injectable only
  • Thin independent footprint; the 50-state and efficacy claims are self-reported

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard